Smell Exploration in Patients With Nasal Polyposis : Study by Functional Magnetic Resonance Imaging

NCT ID: NCT03979716

Last Updated: 2020-11-19

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

60 participants

Study Classification

INTERVENTIONAL

Study Start Date

2019-12-23

Study Completion Date

2021-06-23

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Nasal polyposis (NP) is a disease affecting 4% of the population. This disease is frequently accompanied by olfactory disorders (41%-84% of patients) that affect patients' quality of life.

The aim of this study is to show brain activity differences in olfactory areas before and after surgery in each patient and between patient groups (normosmic, hyposmic and anosmic one) using functional Magnetic Resonance Imaging (fMRI). Brain activity will be measured by the intensity of brain signals and of the size of olfactory areas during olfactory stimulation before and after surgery. We suppose that fMRI could predict whether or not the patient will be able to recover smell after surgery.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Nasal Polyposis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

OTHER

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Anosmic patients

Group Type EXPERIMENTAL

fMRI

Intervention Type DEVICE

fMRI examination

Hyposmic patients

Group Type EXPERIMENTAL

fMRI

Intervention Type DEVICE

fMRI examination

Normosmic patients

Group Type EXPERIMENTAL

fMRI

Intervention Type DEVICE

fMRI examination

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

fMRI

fMRI examination

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients with nasal polyposis managed in the department of otorhinolaryngology and head and neck surgery of Nancy University Hospital,
* Adult Patients,
* Justifying a surgical treatment for nasal polyposis,
* Present hyposmia, anosmia or normosmia before surgery (confirmed by threshold and identification tests of the Sniffin' Stick kit),
* Affiliated with or beneficiary of a social security scheme,
* Having received complete information about the study and having signed an informed consent form.

Exclusion Criteria

* General contraindications to Magnetic Resonance Imaging,
* Female of childbearing age without effective contraception,
* Persons referred in Articles L. 1121-5 to L. 1121-8 and L1122-2 of the Public Health Code,
* Qualitative sense of smell disorder (cacosmia, hyperosmia, phantosmia, parosmia),
* Smell disorders with neurological, post-traumatic, or neurodegenerative origin.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Central Hospital, Nancy, France

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

NGUYEN

Medical Doctor

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Duc Trung NGUYEN, MD, PhD, MPH

Role: PRINCIPAL_INVESTIGATOR

University Hospital, Nancy, France

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

CHRU de Nancy

Nancy, , France

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

France

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Duc Trung NGUYEN, MD, PhD, MPH

Role: CONTACT

Phone: 33383155409

Email: [email protected]

Gabriela HOSSU, PhD

Role: CONTACT

Phone: 33383155096

Email: [email protected]

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Duc Trung NGUYEN, MD, PhD, MPH

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2018-A03215-50

Identifier Type: -

Identifier Source: org_study_id